SpyGlass Pharma SGP
NASDAQ SGP
$29.06 +0.07 (+0.24%)
As of: Sep 4, 2026 · 3:21 PM EDT

SpyGlass Pharma (SGP) Selling, General & Administrative (2025 - 2026)

Analysis

SpyGlass Pharma (SGP) Selling, General & Administrative (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn 582.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 662.10 Mn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -417.00 Mn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn 216.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn - 110.21 Mn
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 593.21 Mn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn 347.92 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 161.89 Mn
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn 247.47 Mn
10 SpyGlass Pharma 974.43 Mn 974.43 Mn - 11.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.03 Mn
Jun 30, 2025 1.96 Mn